Table 2 Crude risk of increasing serum concentrations of uric acid
Odds ratio for outcome | |||||
|---|---|---|---|---|---|
Serum uric acid concentration, μmol/L [mg/dL] | Agatston score >0 vs. Agatston score = 0 | Agatston score >10 vs. Agatston score <10 | |||
Men (n = 1,211) | |||||
Quartile 1 | 155-291 [2.6-4.9] | 1 | 1 | ||
Quartile 2 | 297-333 [5.0-5.6] | 1.17 | (0.71-1.95) | 1.21 | (0.65-2.23) |
Quartile 3 | 339-393 [5.7-6.6] | 1.56 | (0.96-2.54) | 1.62 | (0.91-2.91) |
Quartile 4 | 399-690 [6.7-11.6] | 2.07 | (1.30-3.31) | 2.08 | (1.19-3.67) |
Women (n = 1,287) | |||||
Quartile 1 | 77-196 [1.3-3.3] | 1 | 1 | ||
Quartile 2 | 196-226 [3.3-3.8] | 1.50 | (0.66-3.38) | 1.49 | (0.52-4.22) |
Quartile 3 | 232-274 [3.9-4.6] | 1.44 | (0.65-3.23) | 1.5 | (0.54-4.17) |
Quartile 4 | 280-636 [4.7-10.7] | 2.47 | (1.17-5.22) | 2.93 | (1.15-7.49) |
Overall (n = 2,498) | |||||
Quartile 1 | 77-291 [1.3-4.9] | 1 | 1 | ||
Quartile 2 | 196-333 [3.3-5.6] | 1.25 | (0.81-1.91) | 1.27 | (0.75-2.15) |
Quartile 3 | 232-393 [3.9-6.6] | 1.47 | (0.98-2.22) | 1.54 | (0.93-2.54) |
Quartile 4 | 280-690 [4.7-11.6] | 2.11 | (1.42-3.12) | 2.24 | (1.39-3.60) |